Wang Shunxiang læknir Lifrar- og lungnaskurðlækningar

Wang Shunxiang, útskrifaðist frá læknadeild Hebei Medical University í júlí 1988, dvaldi í skurðaðgerð á fjórða sjúkrahúsi Hebei Medical University. Nú er hann forstöðumaður lifrar- og gallskurðaðgerðar á fjórða sjúkrahúsi Hebei Medical University, yfirlæknir, prófessor, doktor í læknisfræði, doktorsleiðbeinandi. Starfaði sem meðlimur í fastanefnd cholangiocarcinoma fagnefndar Kína gegn krabbameinssamtökum, meðlimur í lifrarkrabbameins fagnefnd Kína gegn krabbameinssamtökum, fastastjóri Hebei krabbameinssamtaka, formaður lifrarkrabbameins fagnefndar Hebei krabbameinssamtaka, formaður lifrarkrabbameins Fagnefnd Hebei krabbameinsvarna- og meðferðarsambands, formaður lifrarkrabbameinsfélags Hebei læknasamtakanna, varaleiðtogi gallveiðahóps Hebei læknasamtakanna og kínverskra lækna meðlimur lifrarlæknahóps, ritstjórnarmeðlimur Chinese Journal of endoscopic surgery og aðrar fræðilegar stöður .

He specializes in hepatobiliary surgery, specializes in the diagnosis and treatment of hepatobiliary, pancreatic and splenic tumors and benign diseases. He organized and implemented the liver transplantation in the fourth hospital of Hebei Medical University, and achieved success. More than 30 postgraduates were trained. “Reform and exploration of general surgery probation teaching” won the first prize of teaching achievement in Hebei Province. “Basic and clinical research on biomarkers of gastric cancer and its regional lymph nodes” won the second prize of science and technology progress of Hebei Province. Study on the expression and significance of VEGF in briskrabbamein, liver cancer and gastric cancer” and “study on the mechanism of invasion and metastasis of liver cancer and its application” won the third prize of science and technology progress of Hebei Province, and published more than 50 papers.

• Lifrar- og lungnaskurðlækningar

• Lifrar- og lungnaskurðlækningar